These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 37627190)

  • 21.
    Zhou W; Wen J; Hua F; Xu W; Lu X; Yin B; Geng D; Guan Y
    Eur J Radiol; 2018 Jul; 104():26-32. PubMed ID: 29857862
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Comparison of effects of 18F-FDG PET-CT and MRI in identifying and grading gliomas.
    Song PJ; Lu QY; Li MY; Li X; Shen F
    J Biol Regul Homeost Agents; 2016; 30(3):833-838. PubMed ID: 27655507
    [TBL] [Abstract][Full Text] [Related]  

  • 23. MRI radiomics to differentiate between low grade glioma and glioblastoma peritumoral region.
    Malik N; Geraghty B; Dasgupta A; Maralani PJ; Sandhu M; Detsky J; Tseng CL; Soliman H; Myrehaug S; Husain Z; Perry J; Lau A; Sahgal A; Czarnota GJ
    J Neurooncol; 2021 Nov; 155(2):181-191. PubMed ID: 34694564
    [TBL] [Abstract][Full Text] [Related]  

  • 24. FDG-PET/CT and MRI for Evaluation of Pathologic Response to Neoadjuvant Chemotherapy in Patients With Breast Cancer: A Meta-Analysis of Diagnostic Accuracy Studies.
    Sheikhbahaei S; Trahan TJ; Xiao J; Taghipour M; Mena E; Connolly RM; Subramaniam RM
    Oncologist; 2016 Aug; 21(8):931-9. PubMed ID: 27401897
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Integrating manual diagnosis into radiomics for reducing the false positive rate of
    Kang F; Mu W; Gong J; Wang S; Li G; Li G; Qin W; Tian J; Wang J
    Eur J Nucl Med Mol Imaging; 2019 Dec; 46(13):2770-2779. PubMed ID: 31321483
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Diagnostic Value of 68Ga PSMA-11 PET/CT Imaging of Brain Tumors-Preliminary Analysis.
    Sasikumar A; Joy A; Pillai MR; Nanabala R; Anees K M; Jayaprakash PG; Madhavan J; Nair S
    Clin Nucl Med; 2017 Jan; 42(1):e41-e48. PubMed ID: 27846000
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Malignant involvement of the peripheral nervous system in patients with cancer: multimodality imaging and pathologic correlation.
    Crush AB; Howe BM; Spinner RJ; Amrami KK; Hunt CH; Johnson GB; Murphy RC; Morreale RF; Peller PJ
    Radiographics; 2014; 34(7):1987-2007. PubMed ID: 25384297
    [TBL] [Abstract][Full Text] [Related]  

  • 28.
    Wilson S; Spriet M; Mur PE; Anishchenko S; Beylin D; Katzman S; Galuppo L
    Vet Radiol Ultrasound; 2021 Sep; 62(5):610-620. PubMed ID: 34148276
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Can FDG-PET/MR help to overcome limitations of sequential MRI and PET-FDG for differential diagnosis between recurrence/progression and radionecrosis of high-grade gliomas?
    Pyatigorskaya N; Sgard B; Bertaux M; Yahia-Cherif L; Kas A
    J Neuroradiol; 2021 May; 48(3):189-194. PubMed ID: 32858062
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Addition of Amide Proton Transfer Imaging to FDG-PET/CT Improves Diagnostic Accuracy in Glioma Grading: A Preliminary Study Using the Continuous Net Reclassification Analysis.
    Sakata A; Okada T; Yamamoto Y; Fushimi Y; Dodo T; Arakawa Y; Mineharu Y; Schmitt B; Miyamoto S; Togashi K
    AJNR Am J Neuroradiol; 2018 Feb; 39(2):265-272. PubMed ID: 29301781
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Diagnostic accuracy of whole-body PET/MRI and whole-body PET/CT for TNM staging in oncology.
    Heusch P; Nensa F; Schaarschmidt B; Sivanesapillai R; Beiderwellen K; Gomez B; Köhler J; Reis H; Ruhlmann V; Buchbender C
    Eur J Nucl Med Mol Imaging; 2015 Jan; 42(1):42-8. PubMed ID: 25112399
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Diagnostic performance of
    Basha MAA; Hamed MAG; Refaat R; AlAzzazy MZ; Bessar MA; Mohamed EM; Ahmed AF; Tantawy HF; Altaher KM; Obaya AA; Afifi AHM
    Jpn J Radiol; 2018 Jun; 36(6):382-393. PubMed ID: 29671193
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Prognostic implication of fluorine-18 fluorodeoxyglucose positron emission tomography/computed tomography in patients with recurrent papillary thyroid cancer.
    Kang JH; Jung DW; Pak KJ; Kim IJ; Kim HJ; Cho JK; Shin SC; Wang SG; Lee BJ
    Head Neck; 2018 Jan; 40(1):94-102. PubMed ID: 29130586
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Locoregional tumour evaluation of squamous cell carcinoma in the head and neck area: a comparison between MRI, PET/CT and integrated PET/MRI.
    Schaarschmidt BM; Heusch P; Buchbender C; Ruhlmann M; Bergmann C; Ruhlmann V; Schlamann M; Antoch G; Forsting M; Wetter A
    Eur J Nucl Med Mol Imaging; 2016 Jan; 43(1):92-102. PubMed ID: 26243264
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Diagnostic value of fluorine-18 fluorodeoxyglucose positron emission tomography/computed tomography in sublingual and submandibular salivary gland tumors.
    Ma S; Liu Y
    Mol Clin Oncol; 2020 Oct; 13(4):27. PubMed ID: 32765874
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Recent and Current Advances in FDG-PET Imaging within the Field of Clinical Oncology in NSCLC: A Review of the Literature.
    Kaseda K
    Diagnostics (Basel); 2020 Aug; 10(8):. PubMed ID: 32764429
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Integrated analysis of dynamic FET PET/CT parameters, histology, and methylation profiling of 44 gliomas.
    Röhrich M; Huang K; Schrimpf D; Albert NL; Hielscher T; von Deimling A; Schüller U; Dimitrakopoulou-Strauss A; Haberkorn U
    Eur J Nucl Med Mol Imaging; 2018 Jul; 45(9):1573-1584. PubMed ID: 29732524
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The value of FDG positron emission tomography/computerised tomography (PET/CT) in pre-operative staging of colorectal cancer: a systematic review and economic evaluation.
    Brush J; Boyd K; Chappell F; Crawford F; Dozier M; Fenwick E; Glanville J; McIntosh H; Renehan A; Weller D; Dunlop M
    Health Technol Assess; 2011 Sep; 15(35):1-192, iii-iv. PubMed ID: 21958472
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Machine learning predictive performance evaluation of conventional and fuzzy radiomics in clinical cancer imaging cohorts.
    Grahovac M; Spielvogel CP; Krajnc D; Ecsedi B; Traub-Weidinger T; Rasul S; Kluge K; Zhao M; Li X; Hacker M; Haug A; Papp L
    Eur J Nucl Med Mol Imaging; 2023 May; 50(6):1607-1620. PubMed ID: 36738311
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Choline-PET/CT in the Differential Diagnosis Between Cystic Glioblastoma and Intraparenchymal Hemorrhage.
    Alongi P; Vetrano IG; Fiasconaro E; Alaimo V; Laudicella R; Bellavia M; Rubino F; Bagnato S; Galardi G
    Curr Radiopharm; 2019; 12(1):88-92. PubMed ID: 30117406
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.